First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.
Br J Cancer
; 114(11): 1199-205, 2016 May 24.
Article
in En
| MEDLINE
| ID: mdl-27140316
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiation-Sensitizing Agents
/
Skin Neoplasms
/
DNA
/
Cholesterol
/
DNA Repair
/
Melanoma
/
Antineoplastic Agents
Limits:
Aged80
Language:
En
Journal:
Br J Cancer
Year:
2016
Type:
Article
Affiliation country:
France